1 results match your criteria: "Imaging Institute of Southern Switzerland Bellinzona and Lugano[Affiliation]"
Radiolabelled choline versus PSMA PET/CT in prostate cancer restaging: a meta-analysis.
Am J Nucl Med Mol Imaging
April 2019
Clinic of Nuclear Medicine and Molecular Imaging, Imaging Institute of Southern Switzerland Bellinzona and Lugano, Switzerland.
Both radiolabelled choline and prostate specific membrane antigen (PSMA) positron emission tomography/computed tomography (PET/CT) could be used in patients with biochemical recurrent prostate cancer (BRPCa). We aimed to perform a meta-analysis about the head-to-head comparison of detection rate (DR) between these methods in BRPCa. A comprehensive literature search of studies listed in PubMed/MEDLINE, EMBASE and Cochrane library databases through October 2018 and regarding the head-to-head comparison of DR between radiolabelled choline and PSMA PET/CT in BRPCa was carried out.
View Article and Find Full Text PDF